DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder

Six months of dialectical behavior therapy (DBT) was more efficacious than a 6‐month course of treatment with a selective serotonin reuptake inhibitor (SSRI) antidepressant in reducing suicide‐related events in patients with borderline personality disorder, a randomized trial has found. However, SSRI treatment was more efficacious than DBT in reducing diagnoses of major depressive disorder at 6 months.